Rheumatoid arthritis
|
Psoriatic arthritis
|
Ankylosing spondylitis
|
---|
Acute phase reactants
|
Acute phase reactants
|
Acute phase reactants
|
Swollen joint count
|
Joint counts
|
Joint counts
|
Tender joint count
|
Axial skeleton
|
Enthesitis
|
Observer global rating
|
Observer global rating
|
Spinal mobility
|
Patient global rating
|
Dactylitis
|
Stiffness
|
Patient pain rating
|
Enthesitis
|
Patient global rating
|
Physical function
|
Psoriasis extent
|
Patient pain rating
|
Joint damage by X-ray
|
Nail involvement
|
Physical function
|
|
Patient pain rating
| |
|
Patient itching rating
| |
|
Physical function
| |
|
Joint damage by X-ray
| |
- Trial outcome measures deemed important for disease modifying anti-rheumatic therapies in rheumatoid arthritis [20, 21], psoriatic arthritis [22], and ankylosing spondylitis [23].